Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats

Role of nitric oxide as a signal crossing the blood-brain barrier

Tomitsune Kitagami, Kiyofumi Yamada, Hideki Miura, Ryo Hashimoto, Toshitaka Nabeshima, Tatsurou Ohta

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

The serious and characteristic side effects of interferon-alpha (IFN-α) therapy on the central nervous system, resulting in such problems as affective disorders or parkinsonism, have led us to investigate the biochemical mechanism of the effects of IFN-α on the monoaminergic neurotransmitter system using an animal model (rats). We first examined the concentrations of tetrahydrobiopterin (BH4) and monoamines in several regions of the brain after the intramuscular injection of IFN-α into rats; the levels of BH4 and dopamine significantly decreased in the amygdala and raphe areas as compared with those of the controls. Based on these results, we further examined the concentrations of BH4 and nitrite (NO2-) plus nitrate (NO3-), metabolites of nitric oxide (NO), in the amygdala and raphe areas after the intramuscular injection of IFN-α; the concentrations of both BH4 and NO2-+NO3- significantly decreased as compared with the control. Furthermore, the addition of NG-monomethyl L-arginine, an inhibitor of NO synthase, after the injection of IFN-α restored the decreased levels of both NO2-+NO3- and BH4 to control levels. As a result, nitric oxide induced by the intramuscular injection of IFN-α was found to cross the blood-brain barrier and suppress both tetrahydrobiopterin biosynthesis and dopamine production in the amygdala and raphe areas.

Original languageEnglish
Pages (from-to)104-114
Number of pages11
JournalBrain Research
Volume978
Issue number1-2
DOIs
Publication statusPublished - 18-07-2003
Externally publishedYes

Fingerprint

Blood-Brain Barrier
Interferon-alpha
Nitric Oxide
Intramuscular Injections
Amygdala
Dopamine
omega-N-Methylarginine
Parkinsonian Disorders
Nitrites
Mood Disorders
Nitric Oxide Synthase
Nitrates
Neurotransmitter Agents
Central Nervous System
Animal Models
Injections
Brain

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Kitagami, Tomitsune ; Yamada, Kiyofumi ; Miura, Hideki ; Hashimoto, Ryo ; Nabeshima, Toshitaka ; Ohta, Tatsurou. / Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats : Role of nitric oxide as a signal crossing the blood-brain barrier. In: Brain Research. 2003 ; Vol. 978, No. 1-2. pp. 104-114.
@article{1a3f45ce910e46b694467e561bde2493,
title = "Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: Role of nitric oxide as a signal crossing the blood-brain barrier",
abstract = "The serious and characteristic side effects of interferon-alpha (IFN-α) therapy on the central nervous system, resulting in such problems as affective disorders or parkinsonism, have led us to investigate the biochemical mechanism of the effects of IFN-α on the monoaminergic neurotransmitter system using an animal model (rats). We first examined the concentrations of tetrahydrobiopterin (BH4) and monoamines in several regions of the brain after the intramuscular injection of IFN-α into rats; the levels of BH4 and dopamine significantly decreased in the amygdala and raphe areas as compared with those of the controls. Based on these results, we further examined the concentrations of BH4 and nitrite (NO2-) plus nitrate (NO3-), metabolites of nitric oxide (NO), in the amygdala and raphe areas after the intramuscular injection of IFN-α; the concentrations of both BH4 and NO2-+NO3- significantly decreased as compared with the control. Furthermore, the addition of NG-monomethyl L-arginine, an inhibitor of NO synthase, after the injection of IFN-α restored the decreased levels of both NO2-+NO3- and BH4 to control levels. As a result, nitric oxide induced by the intramuscular injection of IFN-α was found to cross the blood-brain barrier and suppress both tetrahydrobiopterin biosynthesis and dopamine production in the amygdala and raphe areas.",
author = "Tomitsune Kitagami and Kiyofumi Yamada and Hideki Miura and Ryo Hashimoto and Toshitaka Nabeshima and Tatsurou Ohta",
year = "2003",
month = "7",
day = "18",
doi = "10.1016/S0006-8993(03)02776-8",
language = "English",
volume = "978",
pages = "104--114",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats : Role of nitric oxide as a signal crossing the blood-brain barrier. / Kitagami, Tomitsune; Yamada, Kiyofumi; Miura, Hideki; Hashimoto, Ryo; Nabeshima, Toshitaka; Ohta, Tatsurou.

In: Brain Research, Vol. 978, No. 1-2, 18.07.2003, p. 104-114.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats

T2 - Role of nitric oxide as a signal crossing the blood-brain barrier

AU - Kitagami, Tomitsune

AU - Yamada, Kiyofumi

AU - Miura, Hideki

AU - Hashimoto, Ryo

AU - Nabeshima, Toshitaka

AU - Ohta, Tatsurou

PY - 2003/7/18

Y1 - 2003/7/18

N2 - The serious and characteristic side effects of interferon-alpha (IFN-α) therapy on the central nervous system, resulting in such problems as affective disorders or parkinsonism, have led us to investigate the biochemical mechanism of the effects of IFN-α on the monoaminergic neurotransmitter system using an animal model (rats). We first examined the concentrations of tetrahydrobiopterin (BH4) and monoamines in several regions of the brain after the intramuscular injection of IFN-α into rats; the levels of BH4 and dopamine significantly decreased in the amygdala and raphe areas as compared with those of the controls. Based on these results, we further examined the concentrations of BH4 and nitrite (NO2-) plus nitrate (NO3-), metabolites of nitric oxide (NO), in the amygdala and raphe areas after the intramuscular injection of IFN-α; the concentrations of both BH4 and NO2-+NO3- significantly decreased as compared with the control. Furthermore, the addition of NG-monomethyl L-arginine, an inhibitor of NO synthase, after the injection of IFN-α restored the decreased levels of both NO2-+NO3- and BH4 to control levels. As a result, nitric oxide induced by the intramuscular injection of IFN-α was found to cross the blood-brain barrier and suppress both tetrahydrobiopterin biosynthesis and dopamine production in the amygdala and raphe areas.

AB - The serious and characteristic side effects of interferon-alpha (IFN-α) therapy on the central nervous system, resulting in such problems as affective disorders or parkinsonism, have led us to investigate the biochemical mechanism of the effects of IFN-α on the monoaminergic neurotransmitter system using an animal model (rats). We first examined the concentrations of tetrahydrobiopterin (BH4) and monoamines in several regions of the brain after the intramuscular injection of IFN-α into rats; the levels of BH4 and dopamine significantly decreased in the amygdala and raphe areas as compared with those of the controls. Based on these results, we further examined the concentrations of BH4 and nitrite (NO2-) plus nitrate (NO3-), metabolites of nitric oxide (NO), in the amygdala and raphe areas after the intramuscular injection of IFN-α; the concentrations of both BH4 and NO2-+NO3- significantly decreased as compared with the control. Furthermore, the addition of NG-monomethyl L-arginine, an inhibitor of NO synthase, after the injection of IFN-α restored the decreased levels of both NO2-+NO3- and BH4 to control levels. As a result, nitric oxide induced by the intramuscular injection of IFN-α was found to cross the blood-brain barrier and suppress both tetrahydrobiopterin biosynthesis and dopamine production in the amygdala and raphe areas.

UR - http://www.scopus.com/inward/record.url?scp=0038481998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038481998&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(03)02776-8

DO - 10.1016/S0006-8993(03)02776-8

M3 - Article

VL - 978

SP - 104

EP - 114

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -